Losartan Potassium Tablets, 25 Mg Tablet
Product Images NDC 72162-1696

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium Tablets, 25 Mg (NDC 72162-1696). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1)

A line graph comparing the percentage of patients with a primary endpoint over a 66-month study period for two treatments: atenolol (dotted line) and losartan potassium (solid line). The graph includes an annotation noting an adjusted risk reduction of 13% with losartan potassium, with a p-value of 0.021.*

FDA Label Image

Figure 2 (Figure2)

A line graph comparing the percentage of patients experiencing fatal/non-fatal strokes over study months between two treatments, Atenolol (dotted line) and Losartan Potassium (solid line). The graph shows a lower stroke incidence with Losartan Potassium and notes an adjusted risk reduction of 25% with p=0.001.*

FDA Label Image

Figure 3 (Figure3)

A forest plot chart titled 'Primary Endpoint Events within Demographic Subgroups' comparing event rates and hazard ratios for Losartan and Atenolol in primary composite and stroke events. The chart shows subgroup analyses by age, gender, race, ISH, diabetes, and history of cardiovascular disease with hazard ratios and 95% confidence intervals indicating the relative favors between Losartan and Atenolol.*

FDA Label Image

Figure 4.jpg (Figure4)

A line graph showing the percentage of patients with event outcomes over a period of 48 months, comparing Losartan Potassium and Placebo groups. The graph includes a noted risk reduction of 16.1% with a p-value of 0.022, illustrating a trend difference between the two treatments over time.*

FDA Label Image

Label (Lbl721621696)

Label for Losartan potassium Tablets USP 25 mg, showing a quantity of 1000 tablets. The label includes NDC 72162-1696-0 and states the product is prescription only. The labeler is Bryant Ranch Prepack, Inc., and the manufacturer is Jubilant Cadista Pharmaceuticals Inc. Storage instructions and a pharmacist dispensing note are also present.*

FDA Label Image

Losartan Potassium, Usp (Structure)

Chemical structure diagram of losartan potassium showing its molecular arrangement with atoms and bonds, including a potassium ion (K+). This structural formula corresponds to the active ingredient in Losartan potassium Tablets, 25 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.